Skip to content
thispeptide

SkyRx

SkyRx offers compounded semaglutide through a separate clinical network. Injection and drop claims, outcome guarantees and possible pharmacy partners deserve closer attention than the broad trial figures.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

The contract identifies the clinical and dispensing network, but the product’s evidence still needs careful separation from branded-drug research. Confirm the actual prescription and clinician before paying.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

SkyRx is a platform operated by Viking Man Inc. Its weight page lists semaglutide injections and oral drops, while tirzepatide is marked as coming soon. The terms separate the platform from medical care and pharmacy fulfillment. That distinction matters when deciding who is responsible for the prescription and any medication problem.

What SkyRx prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)Price not published
    • Sublingual (compounded)Price not published

The injection and drop formats should not be treated as having identical clinical evidence. The cited major trials used particular studied products and administration methods. The FAQ identifies a sublingual format, but does not establish equivalent results to the studied injections. Obtain the formulation and instructions directly from the treating clinician.

Who prescribes

A licensed clinician

The terms name a medical network involving Metamorphosis Aesthetics professional entities in several states. Individual prescribers are not identified in the weight offer. Ask which licensed clinician reviews your history and provides treatment. A quick pre-approval quiz is not itself a prescription or a clinical guarantee.

A consultation before any prescription allows a provider to decide whether the requested medicine is appropriate. The weight page describes a free consultation and ongoing access to support. It does not establish one routine medical reassessment interval. Confirm how dose changes and concerning symptoms are reviewed rather than relying solely on automatic refills.

Are labs required?

Not mentioned

The terms identify ZRT Laboratory as a possible testing provider, but do not establish one required weight-program panel or included bill. Ask whether testing is clinically indicated and where results are reviewed. An available laboratory service is different from a defined monitoring protocol included in every prescription.

Ready to start with SkyRx?

Prices and plans are set on the seller's own site.

What it claims, and what it cites

The weight page makes large outcome claims and offers a weight-loss guarantee. The guarantee’s contractual thresholds are not evidence that every patient will achieve those outcomes. BPI Labs appears among the possible pharmacies. FDA warning 699533, dated March 20, 2025, concerned BPI’s epinephrine nasal solution, not a finding about SkyRx’s GLP injection or an identified patient.

Other products and treatment claims

Tirzepatide marked coming soon
A future product card does not establish current prescribing availability.
A standing single-month medication amount
The headline requires a prepaid annual commitment rather than an ordinary single-month purchase.

How it bills

The $199 monthly-looking headline requires a twelve-month subscription paid in full. It is not an ordinary cancellable single-month rate. The contract separately sets renewal processing and guarantee conditions. Confirm the available product, total debit and actual pharmacy before accepting a longer treatment commitment.

For and against

  • For: Medical-group network identified in legal terms
  • For: Possible dispensing pharmacies named
  • For: Prescription consultation requirement stated
  • For: Guarantee qualifications available in the contract
  • Against: Assigned prescriber not individually identified
  • Against: Format claims need product-specific evidence
  • Against: Large headline savings require advance commitment
  • Against: Possible pharmacy’s FDA record requires correct scope

The evidence behind what it sells

Right for

A reader prepared to verify the formulation, medical responsibility and written commitment before considering a longer plan.

Look elsewhere if

Someone expecting a quiz, a broad trial percentage or a guarantee to replace an individualized medical assessment.

Other sellers for weight

SkyRx

Frequently asked questions

Is tirzepatide established as currently available?
The weight page marks its tirzepatide products as coming soon.
Do the cited injection trials prove the same result for oral drops?
No. The exact formulation and delivery route matter to the evidence.
Was the BPI warning issued to SkyRx about its GLP treatment?
No. FDA addressed BPI’s epinephrine nasal product; the terms identify BPI as one possible pharmacy partner.

Sources

  • Weight service, available formats and annual-price footnote
  • Operator, clinical network and guarantee conditions
  • Prescription access and pharmacy fulfillment FAQ
  • General prescription returns policy
  • Medical and pharmacy relationships
  • FDA BPI Labs warning 699533, March 20, 2025

See what SkyRx prescribes today

SkyRx sets its own prices, plans and the states it serves. Check them before you start.

Written by Molly Ward from SkyRx’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.